Estadisticas : Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model

Rodrigo, M.J.
Visitas:1056

533 ( Estados Unidos de América )

175 ( Singapur )

110 ( Reino Unido )

62 ( Hong kong )

58 ( Irlanda )

32 ( Alemania )

16 ( Letonia )

15 ( Brasil )

10 ( Austria )

9 ( Togo )

7 ( China )

5 ( Finlandia )

5 ( Rusia )

4 ( España )

3 ( India )

2 ( Francia )

1 ( Bulgaria )

1 ( Costa de Marfil )

1 ( Suiza )

1 ( Colombia )

1 ( Canadá )

1 ( Sudáfrica )

1 ( Vietnam )

1 ( Qatar )

1 ( México )

1 ( Suecia )

Descargas: 657